Palvella Therapeutics (PVLA)
Palvella Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
2.4M
Short interest
settlement 2026-10-15
9.8
Days to cover
-0.8 days vs prior
80.6%
Short share of volume
2026-11-02
3
Fails to deliver
settlement 2026-10-07
Mon 9 Nov
Next earnings
estimated date
-$9.6M
Insider flow, 90 days
0 buys, 38 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 44 settlements in the table, 44 in the chart. JSONAs of 15 October 2026, short interest in PVLA is 2,407,482 shares, up 81,783 shares over the last month. Over the last 44 readings it ranged from 13,312 shares (15 January 2025) to 2,524,140 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 245K shares a day that is 9.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/pvla" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 2,407,482 | -4.6% | 244,860 | 9.83 |
| 2026-09-30 | 2,524,140 | +8.5% | 236,256 | 10.68 |
| 2026-09-15 | 2,325,699 | +1.5% | 181,436 | 12.82 |
| 2026-08-31 | 2,291,288 | +6.6% | 205,613 | 11.14 |
| 2026-08-14 | 2,149,544 | +3.9% | 167,918 | 12.80 |
| 2026-07-31 | 2,068,268 | -5.0% | 224,496 | 9.21 |
| 2026-07-15 | 2,177,331 | -8.0% | 237,913 | 9.15 |
| 2026-06-30 | 2,366,341 | +13.9% | 374,785 | 6.31 |
| 2026-06-15 | 2,077,095 | -1.9% | 317,852 | 6.53 |
| 2026-05-29 | 2,118,329 | -1.4% | 171,805 | 12.33 |
| 2026-05-15 | 2,147,821 | -1.1% | 242,147 | 8.87 |
| 2026-04-30 | 2,170,623 | +9.7% | 202,515 | 10.72 |
| 2026-04-15 | 1,978,927 | -9.1% | 241,192 | 8.20 |
| 2026-03-31 | 2,176,586 | +12.8% | 292,189 | 7.45 |
| 2026-03-13 | 1,929,147 | +10.6% | 281,916 | 6.84 |
| 2026-02-27 | 1,744,863 | +4.2% | 485,061 | 3.60 |
| 2026-02-13 | 1,674,747 | +22.2% | 305,933 | 5.47 |
| 2026-01-30 | 1,370,113 | +1.2% | 243,265 | 5.63 |
| 2026-01-15 | 1,354,350 | +2.1% | 208,121 | 6.51 |
| 2025-12-31 | 1,326,830 | +60.9% | 327,392 | 4.05 |
| 2025-12-15 | 824,522 | -1.3% | 241,790 | 3.41 |
| 2025-11-28 | 835,488 | +22.8% | 348,569 | 2.40 |
| 2025-11-14 | 680,117 | -9.5% | 189,511 | 3.59 |
| 2025-10-31 | 751,845 | -38.1% | 132,440 | 5.68 |
| 2025-10-15 | 1,215,531 | +11.7% | 221,081 | 5.50 |
| 2025-09-30 | 1,087,968 | +58.0% | 219,362 | 4.96 |
| 2025-09-15 | 688,706 | -5.9% | 105,976 | 6.50 |
| 2025-08-29 | 731,905 | +13.8% | 135,239 | 5.41 |
| 2025-08-15 | 643,134 | -8.3% | 121,388 | 5.30 |
| 2025-07-31 | 701,668 | +10.9% | 244,448 | 2.87 |
| 2025-07-15 | 632,448 | +11.0% | 71,344 | 8.86 |
| 2025-06-30 | 569,923 | +47.2% | 181,369 | 3.14 |
| 2025-06-13 | 387,200 | +43.0% | 95,028 | 4.07 |
| 2025-05-30 | 270,844 | -6.3% | 52,799 | 5.13 |
| 2025-05-15 | 288,965 | +15.0% | 50,101 | 5.77 |
| 2025-04-30 | 251,360 | +37.5% | 108,928 | 2.31 |
| 2025-04-15 | 182,844 | +78.2% | 85,909 | 2.13 |
| 2025-03-31 | 102,620 | +160.7% | 105,358 | 1.00 |
| 2025-03-14 | 39,362 | +55.3% | 73,028 | 1.00 |
| 2025-02-28 | 25,345 | -6.7% | 30,851 | 1.00 |
| 2025-02-14 | 27,175 | +56.6% | 64,765 | 1.00 |
| 2025-01-31 | 17,355 | +30.4% | 40,212 | 1.00 |
| 2025-01-15 | 13,312 | -18.8% | 50,099 | 1.00 |
| 2024-12-31 | 16,389 | -40.8% | 30,748 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of PVLA volume is 80.6%, up 8.0 points over the last five sessions. Over the last 30 readings it ranged from 36.6% (28 September 2026) to 91.7% (23 October 2026). The latest reading is 16.4 points above the 30-session average of 64.2%, on 109K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 88K | 109K | 80.6% | 0 |
| 2026-10-30 | 78K | 120K | 65.2% | 4,683 |
| 2026-10-29 | 100K | 164K | 60.8% | 0 |
| 2026-10-28 | 124K | 147K | 84.7% | 0 |
| 2026-10-27 | 43K | 56K | 78.0% | 0 |
| 2026-10-26 | 23K | 31K | 72.6% | 0 |
| 2026-10-23 | 64K | 70K | 91.7% | 32 |
| 2026-10-22 | 22K | 27K | 81.6% | 0 |
| 2026-10-21 | 40K | 66K | 60.8% | 907 |
| 2026-10-20 | 58K | 92K | 63.0% | 0 |
| 2026-10-19 | 57K | 145K | 39.1% | 0 |
| 2026-10-16 | 50K | 70K | 71.1% | 0 |
| 2026-10-15 | 68K | 104K | 65.0% | 0 |
| 2026-10-14 | 65K | 177K | 36.9% | 0 |
| 2026-10-13 | 54K | 76K | 70.3% | 0 |
| 2026-10-12 | 60K | 88K | 68.0% | 0 |
| 2026-10-09 | 53K | 77K | 69.1% | 0 |
| 2026-10-08 | 80K | 91K | 88.5% | 0 |
| 2026-10-07 | 40K | 64K | 62.4% | 12 |
| 2026-10-06 | 90K | 119K | 75.8% | 2 |
| 2026-10-05 | 42K | 48K | 87.3% | 0 |
| 2026-10-02 | 65K | 143K | 45.6% | 900 |
| 2026-10-01 | 60K | 109K | 54.9% | 7 |
| 2026-09-30 | 36K | 66K | 54.7% | 0 |
| 2026-09-29 | 33K | 67K | 49.4% | 0 |
| 2026-09-28 | 20K | 53K | 36.6% | 0 |
| 2026-09-25 | 29K | 71K | 40.7% | 0 |
| 2026-09-24 | 42K | 86K | 49.5% | 0 |
| 2026-09-23 | 38K | 61K | 62.8% | 0 |
| 2026-09-22 | 65K | 110K | 59.0% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 7 October 2026, the fails-to-deliver balance in PVLA is 3 shares, down 859 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (7 October 2026) to 10,335 shares (20 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-07 | 3 | $128.00 | $384 |
| 2026-09-23 | 862 | $158.13 | $136K |
| 2026-09-22 | 198 | $153.41 | $30K |
| 2026-09-21 | 3,145 | $150.56 | $474K |
| 2026-09-18 | 5,700 | $154.32 | $880K |
| 2026-09-17 | 810 | $151.43 | $123K |
| 2026-09-16 | 4,098 | $151.22 | $620K |
| 2026-09-11 | 779 | $150.39 | $117K |
| 2026-09-10 | 72 | $151.34 | $11K |
| 2026-09-04 | 1,939 | $155.47 | $301K |
| 2026-09-01 | 2,749 | $152.59 | $419K |
| 2026-08-26 | 1,352 | $148.24 | $200K |
| 2026-08-25 | 462 | $145.75 | $67K |
| 2026-08-24 | 204 | $142.04 | $29K |
| 2026-08-20 | 333 | $149.96 | $50K |
| 2026-08-13 | 4,944 | $155.07 | $767K |
| 2026-08-10 | 100 | $157.77 | $16K |
| 2026-08-07 | 307 | $154.93 | $48K |
| 2026-08-06 | 1,213 | $154.91 | $188K |
| 2026-08-05 | 604 | $151.99 | $92K |
| 2026-08-04 | 57 | $140.78 | $8K |
| 2026-08-03 | 167 | $139.04 | $23K |
| 2026-07-31 | 148 | $150.19 | $22K |
| 2026-07-28 | 92 | $141.77 | $13K |
| 2026-07-23 | 762 | $142.18 | $108K |
| 2026-07-21 | 32 | $124.15 | $4K |
| 2026-07-20 | 10,335 | $157.24 | $1.6M |
| 2026-07-16 | 448 | $151.97 | $68K |
| 2026-07-14 | 385 | $146.03 | $56K |
| 2026-07-13 | 303 | $144.76 | $44K |
Insider trades
SEC Form 4, newest first. JSONInsiders at PVLA reported 38 open-market sells worth $9.6M in the last 90 days and no open-market buys. Latest filing: Goin Kathleen (Chief Operating Officer) on 2026-10-21.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-21 | Goin Kathleen | Chief Operating Officer | Sell | 607 | $126.19 | $77K | 0 |
| 2026-10-21 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $125.16 | $208K | 607 |
| 2026-10-21 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $123.62 | $253K | 2K |
| 2026-10-21 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-10-21 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-10-14 | JENKINS GEORGE M | Director | Sell | 505 | $126.55 | $64K | 133K |
| 2026-10-14 | JENKINS GEORGE M | Director | Sell | 597 | $125.33 | $75K | 133K |
| 2026-10-14 | JENKINS GEORGE M | Director | Sell | 920 | $124.37 | $114K | 134K |
| 2026-10-14 | JENKINS GEORGE M | Director | Sell | 3K | $123.29 | $321K | 135K |
| 2026-10-14 | JENKINS GEORGE M | Director | Sell | 2K | $122.62 | $254K | 137K |
| 2026-10-14 | JENKINS GEORGE M | Director | Sell | 476 | $121.14 | $58K | 139K |
| 2026-10-13 | JENKINS GEORGE M | Director | Sell | 922 | $133.72 | $123K | 140K |
| 2026-10-13 | JENKINS GEORGE M | Director | Sell | 579 | $132.40 | $77K | 141K |
| 2026-10-13 | JENKINS GEORGE M | Director | Sell | 1K | $131.49 | $136K | 141K |
| 2026-10-13 | JENKINS GEORGE M | Director | Sell | 990 | $130.48 | $129K | 142K |
| 2026-10-13 | JENKINS GEORGE M | Director | Sell | 2K | $129.23 | $212K | 143K |
| 2026-10-13 | JENKINS GEORGE M | Director | Sell | 2K | $128.52 | $258K | 145K |
| 2026-10-12 | JENKINS GEORGE M | Director | Sell | 817 | $136.44 | $111K | 147K |
| 2026-10-12 | JENKINS GEORGE M | Director | Sell | 1K | $135.50 | $196K | 148K |
| 2026-10-12 | JENKINS GEORGE M | Director | Sell | 3K | $134.21 | $448K | 149K |
| 2026-10-12 | JENKINS GEORGE M | Director | Sell | 2K | $133.25 | $328K | 153K |
| 2026-10-12 | JENKINS GEORGE M | Director | Sell | 5K | $132.62 | $676K | 155K |
| 2026-09-16 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $153.24 | $253K | 0 |
| 2026-09-16 | Goin Kathleen | Chief Operating Officer | Sell | 989 | $152.36 | $151K | 2K |
| 2026-09-16 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $151.16 | $251K | 3K |
| 2026-09-16 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-09-16 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-09-15 | JENKINS GEORGE M | Director | Sell | 560 | $151.33 | $85K | 160K |
| 2026-09-15 | JENKINS GEORGE M | Director | Sell | 263 | $150.40 | $40K | 161K |
| 2026-09-15 | JENKINS GEORGE M | Director | Sell | 954 | $149.38 | $143K | 161K |
| 2026-09-14 | JENKINS GEORGE M | Director | Sell | 2K | $153.10 | $239K | 162K |
| 2026-09-14 | JENKINS GEORGE M | Director | Sell | 6K | $152.12 | $937K | 163K |
| 2026-09-14 | JENKINS GEORGE M | Director | Sell | 6K | $151.46 | $853K | 170K |
| 2026-09-11 | JENKINS GEORGE M | Director | Sell | 1K | $153.06 | $195K | 175K |
| 2026-09-11 | JENKINS GEORGE M | Director | Sell | 5K | $151.72 | $694K | 177K |
| 2026-09-11 | JENKINS GEORGE M | Director | Sell | 7K | $150.62 | $982K | 181K |
| 2026-09-02 | KIRITSY CHRISTOPHER P | Director | Sell | 313 | $157.00 | $49K | 250 |
| 2026-09-02 | KIRITSY CHRISTOPHER P | Director | Exercise or conversion | 313 | $127.20 | $40K | 563 |
| 2026-08-19 | Goin Kathleen | Chief Operating Officer | Sell | 302 | $156.77 | $47K | 0 |
| 2026-08-19 | Goin Kathleen | Chief Operating Officer | Sell | 102 | $155.59 | $16K | 302 |
| 2026-08-19 | Goin Kathleen | Chief Operating Officer | Sell | 400 | $153.00 | $61K | 404 |
| 2026-08-19 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $151.80 | $303K | 804 |
| 2026-08-19 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $151.39 | $227K | 3K |
| 2026-08-19 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-08-19 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-07-15 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $150.25 | $287K | 0 |
| 2026-07-15 | Goin Kathleen | Chief Operating Officer | Sell | 1K | $149.27 | $154K | 2K |
| 2026-07-15 | Goin Kathleen | Chief Operating Officer | Sell | 840 | $148.40 | $125K | 3K |
| 2026-07-15 | Goin Kathleen | Chief Operating Officer | Sell | 522 | $147.14 | $77K | 4K |
| 2026-07-15 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-07-15 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-06-17 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $111.31 | $210K | 25 |
| 2026-06-17 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $110.26 | $264K | 2K |
| 2026-06-17 | Goin Kathleen | Chief Operating Officer | Sell | 25 | $112.23 | $3K | 0 |
| 2026-06-17 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-06-17 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-06-12 | Korenberg Matthew E | CFO, Treasurer | Exercise or conversion | 1K | $13.60 | $14K | 1K |
| 2026-05-20 | Goin Kathleen | Chief Operating Officer | Sell | 48 | $111.89 | $5K | 0 |
| 2026-05-20 | Goin Kathleen | Chief Operating Officer | Sell | 891 | $111.30 | $99K | 48 |
| 2026-05-20 | Goin Kathleen | Chief Operating Officer | Sell | 3K | $110.35 | $371K | 939 |
| 2026-05-20 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-05-20 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-04-15 | Goin Kathleen | Chief Operating Officer | Sell | 100 | $130.33 | $13K | 0 |
| 2026-04-15 | Goin Kathleen | Chief Operating Officer | Sell | 639 | $129.17 | $83K | 100 |
| 2026-04-15 | Goin Kathleen | Chief Operating Officer | Sell | 561 | $128.23 | $72K | 739 |
| 2026-04-15 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $127.13 | $191K | 1K |
| 2026-04-15 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $125.96 | $189K | 3K |
| 2026-04-15 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-04-15 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-03-30 | JENKINS GEORGE M | Director | Buy | 445 | $112.30 | $50K | 188K |
| 2026-03-18 | Goin Kathleen | Chief Operating Officer | Sell | 304 | $119.08 | $36K | 0 |
| 2026-03-18 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $118.37 | $205K | 304 |
| 2026-03-18 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $117.56 | $267K | 2K |
| 2026-03-18 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-03-18 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-02-27 | JENKINS GEORGE M | Director | Buy | 4K | $125.00 | $500K | 187K |
| 2026-02-27 | HERON ELAINE J | Director | Buy | 2K | $125.00 | $300K | 48K |
| 2026-02-18 | Goin Kathleen | Chief Operating Officer | Sell | 1K | $79.97 | $102K | 0 |
| 2026-02-18 | Goin Kathleen | Chief Operating Officer | Sell | 3K | $79.16 | $240K | 1K |
| 2026-02-18 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-02-18 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2026-01-21 | Goin Kathleen | Chief Operating Officer | Sell | 4K | $97.94 | $367K | 0 |
| 2026-01-21 | Goin Kathleen | Chief Operating Officer | Sell | 553 | $95.49 | $53K | 4K |
| 2026-01-21 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2026-01-21 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2025-12-17 | Goin Kathleen | Chief Operating Officer | Sell | 4K | $96.47 | $415K | 0 |
| 2025-12-17 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2025-12-17 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2025-11-19 | Goin Kathleen | Chief Operating Officer | Sell | 3K | $86.51 | $242K | 0 |
| 2025-11-19 | Goin Kathleen | Chief Operating Officer | Sell | 2K | $85.72 | $129K | 3K |
| 2025-11-19 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $9.08 | $20K | 4K |
| 2025-11-19 | Goin Kathleen | Chief Operating Officer | Exercise or conversion | 2K | $7.14 | $15K | 2K |
| 2025-04-09 | JENKINS GEORGE M | Director | Buy | 2K | $20.27 | $50K | 14K |
| 2025-04-09 | JENKINS GEORGE M | Director | Buy | 3K | $20.13 | $50K | 183K |
| 2024-12-18 | JENKINS GEORGE M | Director | Buy | 4K | $12.93 | $52K | 181K |
| 2024-12-13 | BVF I GP LLC | Other | Other transaction | 175K | price not stated in the filing | not stated | 282K |
| 2024-12-13 | BVF I GP LLC | Other | Other transaction | 30K | price not stated in the filing | not stated | 39K |
| 2024-12-13 | BVF I GP LLC | Other | Other transaction | 234K | price not stated in the filing | not stated | 372K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON16 Form 144 notices on file for PVLA worth $14.3M at the prices reported; 6 in the last 90 days worth $9.7M. Latest: Goin Kathleen filed on 2026-10-21 to sell 4,313 shares ($534K) from 2026-10-21.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-21 | Goin KathleenOfficer | 4K | $534K | 0.030% | 2026-10-21 | Piper Sandler & Co Inc |
| 2026-10-13 | JENKINS GEORGE MDirector | 28K | $3.7M | 0.191% | 2026-10-13 | Piper Sandler & Co |
| 2026-09-16 | Goin KathleenOfficer | 4K | $651K | 0.030% | 2026-09-16 | Piper Sandler & Co Inc |
| 2026-09-11 | JENKINS GEORGE MDirector | 28K | $4.1M | 0.191% | 2026-09-11 | Piper Sandler |
| 2026-09-02 | CHRISTOPHER KIRITSYDirector | 375 | $59K | 0.003% | 2026-09-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | Goin KathleenOfficer | 4K | $647K | 0.030% | 2026-08-19 | Piper Sandler & Co Inc |
| 2026-07-15 | Goin KathleenOfficer | 4K | $644K | 0.030% | 2026-07-15 | Piper Sandler & Co Inc |
| 2026-06-17 | Goin KathleenOfficer | 4K | $476K | 0.030% | 2026-06-17 | Piper Sandler & Co Inc |
| 2026-05-20 | Goin KathleenOfficer | 4K | $476K | 0.030% | 2026-05-20 | Piper Sandler & Co Inc |
| 2026-04-15 | Goin KathleenOfficer | 4K | $557K | 0.030% | 2026-04-15 | Piper Sandler & Co Inc |
| 2026-03-18 | Goin KathleenOfficer | 4K | $520K | 0.034% | 2026-03-18 | Piper Sandler and Co |
| 2026-02-19 | Goin KathleenOfficer | 4K | $345K | 0.036% | 2026-02-18 | Piper Sandler & Co Inc |
| 2026-02-18 | Goin KathleenOfficer | 4K | $344K | 0.036% | 2026-02-18 | Piper Sandler and Co |
| 2026-01-21 | Goin KathleenOfficer | 4K | $422K | 0.036% | 2026-01-21 | Piper Sandler & Co Inc |
| 2025-12-17 | Goin KathleenOfficer | 4K | $416K | 0.036% | 2025-12-17 | Piper Sandler & Co Inc |
| 2025-11-19 | Goin KathleenOfficer | 4K | $357K | 0.036% | 2025-11-19 | Piper Sandler & Co Inc |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON11 holders report 5% or more of PVLA in their latest filing, all on Schedule 13G (passive). The largest reported stake is Jennison Associates LLC at 7.7% of the class (1,101,652 shares), filed 2026-10-28 for an event on 2026-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-28 | 13G/Ano. 1 | Jennison Associates LLCinvestment adviser | 1.1M | 7.7% | 2026-09-30 |
| 2026-08-14 | 13G/Ano. 1 | Mathew P. Arensindividual | 769K | 5.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | First Light Asset Management, LLCinvestment adviser | 769K | 5.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | BVF INC/ILcorporation | 673K | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | BVF PARTNERS L P/ILinvestment adviser, partnership | 673K | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | LAMPERT MARK Nindividual | 673K | 4.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | BVF GP HOLDINGS LLCother entity | 618K | 4.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | BVF I GP LLCother entity | 353K | 2.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | BIOTECHNOLOGY VALUE FUND L Ppartnership | 353K | 2.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | BVF II GP LLCother entity | 266K | 1.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | BIOTECHNOLOGY VALUE FUND II LPpartnership | 266K | 1.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | Biotechnology Value Trading Fund OS LPpartnership | 45K | 0.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | BVF Partners OS Ltd.corporation | 45K | 0.3% | 2026-06-30 |
| 2026-08-10 | 13G | PRUDENTIAL FINANCIAL INCparent holding company | 962K | 6.7% | 2026-06-30 |
| 2026-07-29 | 13G | BlackRock, Inc.parent holding company | 813K | 5.7% | 2026-06-30 |
| 2026-02-13 | 13G/Ano. 3 | Frazier Life Sciences Public Fund, L.P.partnership | 706K | 6.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | FHMLSP, L.P.partnership | 706K | 6.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | FHMLSP, L.L.C.other entity | 706K | 6.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | Frazier Life Sciences XI, L.P.partnership | 8K | 0.1% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | FHMLS XI, L.P.partnership | 8K | 0.1% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | FHMLS XI, L.L.C.other entity | 8K | 0.1% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | Frazier Life Sciences X, L.P.partnership | 5K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | Patrick J. Heronindividual | 5K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | James N. Topperindividual | 5K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | Frazier Life Sciences XII, L.P.partnership | 4K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | FHMLS XII, L.P.partnership | 4K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | FHMLS XII, L.L.C.other entity | 4K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | FHMLS X, L.P.partnership | 5K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | FHMLS X, L.L.C.other entity | 5K | 0.0% | 2025-12-31 |
| 2025-11-13 | 13G/Ano. 1 | AARON COWENparent holding company, individual | 822K | 7.4% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | SUVRETTA CAPITAL MANAGEMENT, LLCinvestment adviser, other entity | 822K | 7.4% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | AVERILL MASTER FUND, LTD.corporation | 714K | 6.5% | 2025-09-30 |
13F holders
Tracked managers holding PVLA at their latest 13F. JSON5 of the 30 tracked managers held PVLA at their latest 13F, $18.9M in total at quarter-end prices. Renaissance Technologies is the largest at $8.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 53K | $8.1M | 0.01% | +35K |
| Millennium Management | 2026-06-30 | 52K | $8.0M | 0.00% | -41K |
| Two Sigma Investments | 2026-06-30 | 12K | $1.9M | 0.00% | +7K |
| Citadel Advisors | 2026-06-30 | 4K | $538K | 0.00% | -17K |
| AQR Capital Management | 2026-06-30 | 2K | $354K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Palvella Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Palvella Therapeutics (PVLA), SEC CIK 1583648, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-07.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-21.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-28.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-04.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-21.JSON and CSV
- Company record
- EDGAR filing index for CIK 1583648Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of PVLA is sold short?
2,407,482 shares were held short at the 2026-10-15 settlement, 9.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is PVLA's daily short volume?
On 2026-11-02, 88,176 of the 109,434 PVLA shares reported to FINRA were sold short, 80.6% of the day's reported volume. Short volume is a flow for one day, not a position.
Does PVLA have fails to deliver?
The SEC's latest file shows 3 PVLA shares failed to deliver at settlement 2026-10-07. Fails are reported per settlement date and published twice a month with a lag.
Are PVLA insiders buying or selling?
Insiders at PVLA reported 38 open-market sells worth $9.6M in the last 90 days and no open-market buys. Latest filing: Goin Kathleen (Chief Operating Officer) on 2026-10-21.
Have PVLA insiders filed to sell?
16 Form 144 notices on file for PVLA worth $14.3M at the prices reported; 6 in the last 90 days worth $9.7M. Latest: Goin Kathleen filed on 2026-10-21 to sell 4,313 shares ($534K) from 2026-10-21.
Who owns 5% or more of PVLA?
11 holders report 5% or more of PVLA in their latest filing, all on Schedule 13G (passive). The largest reported stake is Jennison Associates LLC at 7.7% of the class (1,101,652 shares), filed 2026-10-28 for an event on 2026-09-30.
Which tracked 13F managers own PVLA?
5 of the 30 tracked 13F managers held PVLA shares at their latest filing, $18.9M in all. The largest: Renaissance Technologies (53K shares, $8.1M), Izzy Englander's Millennium Management (52K shares, $8.0M), Two Sigma Investments (12K shares, $1.9M), Ken Griffin's Citadel Advisors (4K shares, $538K), Cliff Asness's AQR Capital Management (2K shares, $354K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.